Incorporation of primary patient‐derived glycoproteins into authentic infectious hepatitis C virus particles
Juliane Doerrbecker, Martina Friesland, Nina Riebesehl, Corinne Ginkel, Patrick Behrendt, Richard J.P. Brown, Sandra Ciesek, Heiner Wedemeyer, Christoph Sarrazin, Lars Kaderali, Thomas Pietschmann, Eike Steinmann – 27 April 2014 – The Japanese fulminant hepatitis‐1 (JFH1)‐based hepatitis C virus (HCV) infection system has permitted analysis of the complete viral replication cycle in vitro. However, lack of robust infection systems for primary, patient‐derived isolates limits systematic functional studies of viral intrahost variation and vaccine development.